Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients ; volume:31 ; number:1 ; day:11 ; month:9 ; year:2012 ; pages:1-10 ; date:12.2012
Journal of experimental & clinical cancer research ; 31, Heft 1 (11.9.2012), 1-10, 12.2012
- Creator
-
Coco, Claudio
Zannoni, Gian Franco
Caredda, Emanuele
Sioletic, Stefano
Boninsegna, Alma
Migaldi, Mario
Rizzo, Gianluca
Bonetti, Luca Reggiani
Genovese, Giannicola
Stigliano, Egidio
Cittadini, Achille
Sgambato, Alessandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-31-71
- URN
-
urn:nbn:de:101:1-2021080706524717154695
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Coco, Claudio
- Zannoni, Gian Franco
- Caredda, Emanuele
- Sioletic, Stefano
- Boninsegna, Alma
- Migaldi, Mario
- Rizzo, Gianluca
- Bonetti, Luca Reggiani
- Genovese, Giannicola
- Stigliano, Egidio
- Cittadini, Achille
- Sgambato, Alessandro
- SpringerLink (Online service)
Other Objects (12)
CD133 antigen expression in ovarian cancer
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
CD133-regulated nucleophosmin expression in human colon cancer cells
Prognostic impact of CD133 expression in Endometrial Cancer Patients
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
CD133 antigen expression in ovarian cancer
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
CD133-regulated nucleophosmin expression in human colon cancer cells
Prognostic impact of CD133 expression in Endometrial Cancer Patients
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
CD133 antigen expression in ovarian cancer
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
CD133-regulated nucleophosmin expression in human colon cancer cells
Prognostic impact of CD133 expression in Endometrial Cancer Patients
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma